They have given no evidence whatsoever that they have taken advantage of any market gaps but say they’re always ready to do so. They have refused to provide earnings forecasts and that pretty well says it all. They’ve had 2 years to organise Myring approval. They have bought into E4 that may, may, may, improve outcomes for patients.....MYX fails to impress the market and leaves the market far from impressed. The buck stops with the CEO and the board. They don’t even have a workable turn around strategy (meaning more of the same) because they fail to openly acknowledge their previous mistakes. There is no sense of urgency whatsoever. Their communication is abysmal. They have kicked the can cheerily down the road. I’d take Scott’s job for 2 mill myself, doesn’t seem too difficult just make a few promises and travel the world on an all expenses credit card and milk it for all it’s worth. He missed his calling, he would have fitted in perfectly with the pollies but this is a far more lucrative junket and bugger all accountability!
MYX Price at posting:
44.5¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)